p53-mediated heterochromatin reorganization regulates its cell fate decisions.

Translating the Histone Code

Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · see citing works

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Blinded by the Light: The Growing Complexity of p53

Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works

Requirement for p53 and p21 to Sustain G ₂ Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · see citing works

hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase

Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,653 · see citing works

DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

Pommier, Y. G., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,842 · see citing works

Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability

Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766 · see citing works

Suv39h-Mediated Histone H3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric Heterochromatin

Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,248 · see citing works

Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2876 · Cited by 1,099 · see citing works

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-973 · Cited by 951 · see citing works

Histone Methyltransferases Direct Different Degrees of Methylation to Define Distinct Chromatin Domains

Rice, J. C., Briggs, S. D., Ueberheide, B. M., Barber, C. M., Shabanowitz, J., Hunt, D. F., Shinkai, Y., & Allis, C. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00479-9 · Cited by 828 · see citing works

Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53

Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794 · see citing works

p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage

Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · see citing works

Chromatin Challenges during DNA Replication and Repair

Groth, A., Rocha, W., Verreault, A., & Almouzni, G. (2007) · Cell · doi:10.1016/j.cell.2007.01.030 · Cited by 733 · see citing works

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728 · see citing works

Histone lysine methylation: a signature for chromatin function

Sims, R. J., Nishioka, K., & Reinberg, D. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.007 · Cited by 684 · see citing works

The genetics of the p53 pathway, apoptosis and cancer therapy

Vázquez, A., Bond, E. E., Levine, A. J., & Bond, G. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2656 · Cited by 674 · see citing works

The Nucleosome

Khorasanizadeh, S. (2004) · Cell · doi:10.1016/s0092-8674(04)00044-3 · Cited by 672 · see citing works

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708917105 · Cited by 660 · see citing works

The SWI/SNF complex — chromatin and cancer

Roberts, C. W. M., & Orkin, S. H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1273 · Cited by 603 · see citing works

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

Mirza, A., McGuirk, M., Hockenberry, T., Wu, Q. J., Ashar, H. R., Black, S., Wen, S. F., Wang, L., Kirschmeier, P. T., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 530 · see citing works

p53 post-translational modification: deregulated in tumorigenesis

Dai, C., & Gu, W. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523 · see citing works

Epigenetics in cancer: Targeting chromatin modifications

Ellis, L., Atadja, P. W., & Johnstone, R. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0860 · Cited by 483 · see citing works

Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression

Godár, S., Ince, T. A., Bell, G. W., Feldser, D. M., Donaher, J. L., Bergh, J. C. S., Liu, A. Y., Miu, K., Watnick, R. S., Reinhardt, F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.006 · Cited by 455 · see citing works

p53 regulates a G 2 checkpoint through cyclin B1

Innocente, S. A., Abrahamson, J., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 435 · see citing works

Dynamics and interplay of nuclear architecture, genome organization, and gene expressionPreprint

Schneider, R., & Grosschedl, R. (2007) · Genes & Development · doi:10.1101/gad.1604607 · Cited by 421 · see citing works

Specificity of the HP1 chromo domain for the methylated N‐terminus of histone H3

Jacobs, S. A., Taverna, S. D., Zhang, Y., Briggs, S. D., Li, J., Eissenberg, J. C., Allis, C. D., & Khorasanizadeh, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5232 · Cited by 418 · see citing works

Linking the epigenetic ‘language’ of covalent histone modifications to cancer

Hake, S. B., Xiao, A., & Allis, C. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601575 · Cited by 384 · see citing works

Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus

Berk, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209040 · Cited by 375 · see citing works

Mdm2-mediated ubiquitylation: p53 and beyond

Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354 · see citing works

Serum insulin-like growth factor-I and breast cancer

Toniolo, P. G., Bruning, P. F., Akhmedkhanov, A., Bonfrèr, J. M. G., Koenig, K. L., Lukanova, A., Shore, R. E., & Zeleniuch‐Jacquotte, A. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001201)88:5 · Cited by 341 · see citing works

Isolation and Characterization of Suv39h2 , a Second Histone H3 Methyltransferase Gene That Displays Testis-Specific Expression

O’Carroll, D., Scherthan, H., Peters, A. H. F. M., Opravil, S., Haynes, A. R., Laible, G., Rea, S., Schmid, M., Lebersorger, A., Jerratsch, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9423-9433.2000 · Cited by 304 · see citing works

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53

Sugrue, M. M., Shin, D. Y., Lee, S. W., & Aaronson, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9648 · Cited by 290 · see citing works

The impact of acetylation and deacetylation on the p53 pathway

Brooks, C. L., & Gu, W. J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1063-9 · Cited by 279 · see citing works

A polymorphic microsatellite that mediates induction of PIG3 by p53

Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M. (2002) · Nature Genetics · doi:10.1038/ng836 · Cited by 274 · see citing works

Differential expression of selected histone modifier genes in human solid cancers

Özdağ, H., Teschendorff, A. E., Ahmed, A. A., Hyland, S. J., Blenkiron, C., Bobrow, L., Veerakumarasivam, A., Burtt, G. J., Subkhankulova, T., Arends, M. J., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-90 · Cited by 258 · see citing works

Survival Signaling by Notch1: Mammalian Target of Rapamycin (mTOR)–Dependent Inhibition of p53

Mungamuri, S. K., Yang, X., Thor, A. D., & Somasundaram, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3830 · Cited by 246 · see citing works

Transcriptional role of p53 in interferon-mediated antiviral immunity

Muñoz‐Fontela, C., Macip, S., Martínez‐Sobrido, L., Brown, L. M., Ashour, J., García‐Sastre, A., Lee, S. W., & Aaronson, S. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080383 · Cited by 244 · see citing works

Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells

Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., & Issa, J. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002037 · Cited by 235 · see citing works

SWI/SNF Complex Interacts with Tumor Suppressor p53 and Is Necessary for the Activation of p53-mediated Transcription

Lee, D., Kim, J. W., Seo, T., Hwang, S. G., Choi, E., & Choe, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111987200 · Cited by 230 · see citing works

p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage

Rubbi, C. P., & Milner, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg082 · Cited by 229 · see citing works

p21/CDKN1A Mediates Negative Regulation of Transcription by p53

Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227 · see citing works

p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53

Li, F., Igarashi, M., Leung, J., Sugrue, M. M., Lee, S. W., & Aaronson, S. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202615 · Cited by 207 · see citing works

BRD7 is a candidate tumour suppressor gene required for p53 function

Drost, J., Mantovani, F., Tocco, F., Elkon, R., Comel, A., Holstege, H. H., Kerkhoven, R. M., Jonkers, J., Voorhoeve, P. M., Agami, R., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2038 · Cited by 199 · see citing works

Smarcc1/Baf155 Couples Self-Renewal Gene Repression with Changes in Chromatin Structure in Mouse Embryonic Stem Cells

Schaniel, C., Ang, Y.-S., Ratnakumar, K., Cormier, C., James, T., Bernstein, E., Lemischka, I. R., & Paddison, P. J. (2009) · Stem Cells · doi:10.1002/stem.223 · Cited by 152 · see citing works

Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.

Bosch-Presegué, L., Raurell-Vila, H., Marazuela-Duque, A., Kane-Goldsmith, N., Valle, A., Oliver, J., Serrano, L., & Vaquero, A. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.034 · Cited by 138 · see citing works

Medicinal Chemistry of Paclitaxel and its Analogues

Fu, Y., Li, S., Zu, Y., Yang, G., Yang, Z., Luo, M., Jiang, S., Wink, M., & Efferth, T. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789352277 · Cited by 130 · see citing works

The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells

Naidu, S. R., Love, I. M., Imbalzano, A. N., Grossman, S. R., & Androphy, E. J. (2009) · Oncogene · doi:10.1038/onc.2009.121 · Cited by 122 · see citing works

Heterochromatin silencing of p53 target genes by a small viral protein

Soria, C. T., Estermann, F. E., Espantman, K. C., & O’Shea, C. C. (2010) · Nature · doi:10.1038/nature09307 · Cited by 122 · see citing works

p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1

Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G. S., Sawaya, B. E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.193 · Cited by 115 · see citing works

The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise

Mandinova, A., & Lee, S. W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001366 · Cited by 113 · see citing works

Mammalian Su(var) Genes in Chromatin Control

Fodor, B. D., Shukeir, N., Reuter, G., & Jenuwein, T. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113225 · Cited by 105 · see citing works

Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G 2 /M Arrest in Human Cells

Badie, C., Itzhaki, J. E., Sullivan, M. J., Carpenter, A. J., & Porter, A. C. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2358-2366.2000 · Cited by 83 · see citing works

Chromatin and transcription: histones continue to make their marks

Jaskelioff, M., & Peterson, C. (2003) · Nature Cell Biology · doi:10.1038/ncb0503-395 · Cited by 79 · see citing works

Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain

Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 69 · see citing works

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 61 · see citing works

Expression of the Cell Cycle Phosphatase cdc25C Is Down-Regulated by the Tumor Suppressor Protein p53 but Not by p73

Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M. W., Mössner, J., & Engeland, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5040 · Cited by 54 · see citing works

Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy.

Allison, S. J., & Milner, J. (2003) · PubMed · Cited by 42 · see citing works

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works

The transcription factor p53: Not a repressor, solely an activator.

Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153 · see citing works

Epigenetic Regulation of Cellular Senescence and Aging

Sidler, C. L., Kovalchuk, O., & Kovalchuk, I. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00138 · Cited by 147 · see citing works

TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activityPreprint

Sammons, M. A., Zhu, J., Drake, A. M., & Berger, S. L. (2014) · Genome Research · doi:10.1101/gr.181883.114 · Cited by 114 · see citing works

USP7 Is a Master Regulator of Genome Stability

Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works

Mechanisms of impaired differentiation in rhabdomyosarcoma

Keller, C., & D, D. C. G. (2013) · FEBS Journal · doi:10.1111/febs.12421 · Cited by 115 · see citing works

Replication Stress and Chromatin Context Link ATM Activation to a Role in DNA Replication

Olcina, M. M., Foskolou, I. P., Anbalagan, S., Senra, J. M., Pires, I. M., Jiang, Y., Ryan, A. J., & Hammond, E. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.019 · Cited by 110 · see citing works

USP7 - a crucial regulator of cancer hallmarks

Saha, G., Roy, S., Basu, M., & Ghosh, M. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188903 · Cited by 106 · see citing works

p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes

Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2013) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 93 · see citing works

PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer

Lee, K.-H., Park, J.-W., Sung, H.-S., Choi, Y.-J., Kim, W., Lee, H. S., Chung, H.-J., Shin, H.-W., Cho, C.-H., Kim, T.-Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.219 · Cited by 83 · see citing works

Lysine-specific modifications of p53: a matter of life and death?

Marouco, D. M., Garabadgiu, A. V., Melino, G., & Barlev, N. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1436 · Cited by 81 · see citing works

Transposable elements as tissue-specific enhancers in cancers of endodermal lineage

Karttunen, K., Patel, D., Xia, J., Fei, L., Palin, K., Aaltonen, L., & Sahu, B. (2022) · bioRxiv · doi:10.1038/s41467-023-41081-4 · Cited by 66 · see citing works

H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK

Olcina, M. M., Leszczyńska, K. B., Senra, J. M., Isa, N. F., Harada, H., & Hammond, E. M. (2015) · Oncogene · doi:10.1038/onc.2015.134 · Cited by 77 · see citing works

Jumonji histone demethylases as emerging therapeutic targets

Park, S. Y., Park, J., & Chun, Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.026 · Cited by 74 · see citing works

G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer’s disease

Hanna, R., Flamier, A., Barabino, A., & Bernier, G. (2021) · Nature Communications · doi:10.1038/s41467-021-22129-9 · Cited by 71 · see citing works

p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression

Zheng, H., Chen, L., Pledger, W. J., Fang, J., & Chen, J. (2013) · Oncogene · doi:10.1038/onc.2013.6 · Cited by 65 · see citing works

USP7 enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation.

Mungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54 · see citing works

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers

Mungamuri, S. K., Murk, W. K., Grumolato, L., Bernstein, E., & Aaronson, S. A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.009 · Cited by 52 · see citing works

Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer

Lu, W., & Katzenellenbogen, B. S. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0298-1 · Cited by 52 · see citing works

Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma

Fang, Y., Zhang, M., He, Y., Li, C., Fang, H., Xu, P., Cheng, S., Zhao, Y. F., Feng, Y., Liu, Q., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01626-x · Cited by 45 · see citing works

Mdm2 as a chromatin modifier

Wienken, M., Moll, U. M., & Dobbelstein, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw046 · Cited by 44 · see citing works

The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View

Li, B., Zheng, Y., & Yang, L. (2019) · Journal of Cancer · doi:10.7150/jca.28254 · Cited by 42 · see citing works

Control of p53-dependent transcription and enhancer activity by the p53 family member p63

Uzunbas, G. K., Ahmed, F., & Sammons, M. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007965 · Cited by 41 · see citing works

Stra6, a retinoic acid-responsive gene, participates in p53-induced apoptosis after DNA damage

Carrera, S., Cuadrado‐Castano, S., Samuel, J., Jones, G. D. D., Villar, E., Lee, S. W., & Macip, S. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.14 · Cited by 40 · see citing works

p53 Down-regulates SETDB1 gene expression during paclitaxel induced-cell death

Noh, H.-J., Kim, K.-A., & Kim, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.053 · Cited by 38 · see citing works

Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin

Liu, K., Lin, F., Graves, J. D., Lee, Y.-J., & Lin, W.-C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619832114 · Cited by 35 · see citing works

KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage

Castellini, L., Moon, E. J., Razorenova, O. V., Krieg, A. J., von Eyben, R., & Giaccia, A. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1281 · Cited by 35 · see citing works

Heterochromatin protects retinal pigment epithelium cells from oxidative damage by silencing p53 target genes

Gong, L., Liu, F., Xiong, Z., Qi, R., Luo, Z., Gong, X., Nie, Q., Sun, Q., Liu, Y.-F., Qing, W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715237115 · Cited by 32 · see citing works

Spatially coordinated heterochromatinization of long synaptic genes in fragile X syndrome

Malachowski, T., Chandradoss, K., Boya, R., Zhou, L., Cook, A. L., Su, C., Pham, K., Haws, S. A., Kim, J. H., Ryu, H.-S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.019 · Cited by 26 · see citing works

Comprehensive characterization of the epigenetic landscape in Multiple Myeloma

Alaterre, E., Ovejero, S., Herviou, L., de Boussac, H., Papadopoulos, G. L., Kulis, M., Boireau, S., Robert, N., Requirand, G., Bruyer, A., et al. (2022) · Theranostics · doi:10.7150/thno.54453 · Cited by 30 · see citing works

Epigenetic modulation of metabolic decisions

Öst, A., & Pospisilik, J. A. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.12.005 · Cited by 28 · see citing works

SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD

Chen, T.-T., Wu, S., Ho, S., Chuang, H., Liu, C., Chan, Y., Kuo, L.-W., Feng, P., Liu, W., Chen, K.-Y., et al. (2017) · Scientific Reports · doi:10.1038/srep46667 · Cited by 25 · see citing works

Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters

Mungamuri, S. K., Wang, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2014) · Oncogene · doi:10.1038/onc.2014.198 · Cited by 24 · see citing works

Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma

Puzio‐Kuter, A. M., Laddha, S. V., Castillo-Martín, M., Sun, Y., Cordon‐Cardo, C., Chan, C. S., & Levine, A. J. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.27 · Cited by 24 · see citing works

A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer

Chen, B., Wang, J., Wang, J., Wang, H., Gu, X., Tang, L., & Feng, X. (2018) · Bioscience Reports · doi:10.1042/bsr20180678 · Cited by 23 · see citing works

The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer

Saha, G., & Ghosh, M. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119908 · Cited by 17 · see citing works

p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition

Sheikh, T., & Sen, E. (2021) · Cytokine · doi:10.1016/j.cyto.2020.155418 · Cited by 15 · see citing works

SUV39H1 downregulation induces deheterochromatinization of satellite regions and senescence after exposure to ionizing radiation

Sidler, C. L., Li, D., Wang, B., Kovalchuk, I., & Kovalchuk, O. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00411 · Cited by 15 · see citing works

p53 and TDG are dominant in regulating the activity of the human de novo DNA methyltransferase DNMT3A on nucleosomes

Sandoval, J. E., & Reich, N. O. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016125 · Cited by 12 · see citing works

Dephosphorylation of p53 Ser 392 Enhances Trimethylation of Histone H3 Lys 9 via SUV39h1 Stabilization in CK2 Downregulation-Mediated Senescence.

Park, J., & Bae, Y. (2019) · PubMed Central · doi:10.14348/molcells.2019.0018 · Cited by 10 · see citing works

Cell-free extract from porcine induced pluripotent stem cells can affect porcine somatic cell nuclear reprogramming

No, J.-G., Choi, M.-K., Kwon, D., Yoo, J. G., Yang, B.-C., Park, J.-K., & Kim, D. (2015) · Journal of Reproduction and Development · doi:10.1262/jrd.2014-078 · Cited by 8 · see citing works

Aflatoxin B1 downregulates ARID3 genes to overcome senescence for inducing hepatocellular carcinoma

Ara, D., Dheeravath, S., & Mungamuri, S. K. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.108114 · Cited by 6 · see citing works

Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML.

Amiri, ‏., Mohammadi, M. H., Rafiee, M., Ghezelbash, B., Salari, S., & Farsani, M. A. (2021) · Current Research in Translational Medicine · doi:10.1016/j.retram.2021.103311 · Cited by 6 · see citing works

Hsa_circ_0080229 upregulates the expression of murine double minute-2 (MDM2) and promotes glioma tumorigenesis and invasion via the miR-1827 sponging mechanism

Zhou, Z., Zheng, X., Mei, X., Li, W., Qi, S., Deng, Y., & Lei, B. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-7123 · Cited by 5 · see citing works

Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells

Miciak, J. J., Petrova, L., Sajwan, R., Pandya, A., Deckard, M., Munoz, A. J., & Bunz, F. (2025) · Oncotarget · doi:10.18632/oncotarget.28690 · Cited by 3 · see citing works

Role of SUV39H2 in shaping the malignant phenotype of triple-negative breast cancer

Wang, Z.-W., Hu, S., Chen, Y., Lu, Y., Li, S.-F., Deng, Y., & Jiang, H.-T. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1679640 · Cited by 3 · see citing works

A histone demethylase inhibitor, methylstat, inhibits angiogenesis in vitro and in vivo

Cho, Y., Kim, K. H., Cho, Y. S., Xu, W., Wang, X., & Kwon, H. J. (2014) · RSC Advances · doi:10.1039/c4ra07154a · Cited by 3 · see citing works

Capturing variations in nuclear phenotypes

Raman, S., Singh, S., Pécot, T., Caserta, E., Huang, K., Rittscher, J., Leone, G. W., & Machiraju, R. (2019) · Journal of Computational Science · doi:10.1016/j.jocs.2019.07.001 · Cited by 2 · see citing works

p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer

Aylon, Y., Furth, N., Pirona, A. C., Lavie, A., Fedorova, O., Hassin, O., Padrão, N., Steinmetz, M., Sarusi-Portuguez, A., Fellus‐Alyagor, L., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522646122 · Cited by 2 · see citing works

53BP1 regulates p53-E2F7-dependent transcriptional gene repression and participates in the Fanconi anemia pathway

Fu, Y.-D., Wu, W., Zhang, M., Rong, Z., Lin, B., Zhou, X., Li, D., Shi, X., Guo, J., Ma, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116152 · Cited by 1 · see citing works

Modeling wild type and mutant p53 in telomerase-immortalized human cellsPreprint

Miciak, J. J., & Bunz, F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.22.546141 · Cited by 1 · see citing works

Keeping p53 targets quiet

David, R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3347

Transcription Analysis of a Histones Modifiers Panel Coupled with Tumor Suppressor Genes Displayed Frequent Changes in Acute Myeloid Leukemia-Related GenesPreprint

Amiri, ‏., Mohammadi, M. H., Rafiee, M., Ghezelbash, B., Salari, S., & Farsani, M. A. (2020) · doi:10.21203/rs.3.rs-34933/v1

Keeping p53 targets quiet

David, R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3347

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 61 · see citing works

Relationship between Histone H3 Lysine 9 Methylation, Transcription Repression, and Heterochromatin Protein 1 Recruitment

Stewart, M. D., Li, J., & Wong, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2525-2538.2005 · Cited by 352 · see citing works

p53-Targeted LSD1 Functions in Repression of Chromatin Structure and Transcription In Vivo

Tsai, W.-W., Nguyen, T. T. T., Shi, Y., & Barton, M. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00287-08 · Cited by 64 · see citing works

Repression of p53 activity by Smyd2-mediated methylation

Huang, J. L., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., Kubicek, S., Opravil, S., Jenuwein, T., & Berger, S. L. (2006) · Nature · doi:10.1038/nature05287 · Cited by 626 · see citing works